Beijing Strong Biotechnologies,Inc. (SHE:300406)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biomedicine	1.36B	1.66B	1.74B	1.51B	1.60B
Biomedicine Growth	-18.29%	-4.75%	15.27%	-5.53%	88.58%
Total	1.36B	1.66B	1.74B	1.51B	1.60B
Total Growth	-18.29%	-4.75%	15.27%	-5.53%	88.58%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	1.30B	1.62B	1.71B	1.48B	1.57B
China Growth	-19.61%	-5.51%	15.64%	-5.90%	88.17%
Foreign	56.62M	43.25M	31.67M	29.36M	28.06M
Foreign Growth	30.90%	36.57%	7.87%	4.62%	130.39%
Total	1.36B	1.66B	1.74B	1.51B	1.60B
Total Growth	-18.29%	-4.75%	15.49%	-5.71%	88.78%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error